Over 20 million Americans live with peripheral neuropathy. Among adults over 65 with diabetes, the number approaches 50%. The standard treatment path for most of them is pain medication: drugs that dull the signal without touching the damaged nerve. Red light therapy, also called photobiomodulation, takes a fundamentally different approach. It uses specific wavelengths of light to penetrate tissue and stimulate repair at the cellular level, targeting the nerve damage itself rather than masking what that damage feels like. A growing body of peer-reviewed research now supports its effectiveness for reducing neuropathic pain, accelerating nerve regeneration, and restoring sensory function, all without pharmaceuticals or invasive procedures.
Here's what the science says, what's actually happening inside damaged nerve tissue when light hits it, and what a realistic treatment protocol looks like.
Key Takeaways
-
Red light therapy (photobiomodulation) addresses the underlying nerve damage rather than masking symptoms by stimulating cellular energy production, nerve growth factors, and myelin repair to restore function at the cellular level.
-
A growing body of peer-reviewed clinical research confirms that photobiomodulation reduces neuropathic pain, improves sensory function, and accelerates nerve healing across multiple neuropathy types, including diabetic and chemotherapy-induced peripheral neuropathy.
-
Effective neuropathy treatment requires a consistent, multi-component approach: daily red light therapy sessions combined with nerve-support supplementation, targeted exercise, and dietary changes to create the conditions damaged nerves need to repair.
What Neuropathy Does to Your Nervous System
Peripheral neuropathy is nerve damage, most commonly affecting the hands and feet. When peripheral nerves sustain damage, they lose the ability to transmit signals properly between the brain and the body's extremities. The result is a collection of symptoms most people recognize: burning pain, numbness, tingling, muscle weakness, loss of coordination, and in advanced cases, a near-total loss of protective sensation in the feet that dramatically increases fall risk.
Diabetes is the leading cause. Sustained high blood sugar gradually destroys nerve fibers over time, producing what's clinically called diabetic neuropathy. Chemotherapy is another major driver; the drugs that kill cancer cells also damage peripheral nerves, sometimes permanently. Other causes include autoimmune conditions, infections, physical injuries, vitamin deficiencies, and certain medications.
The trajectory without intervention is predictable and grim. Occasional tingling becomes constant pain. Constant pain becomes numbness. Numbness becomes instability, falls, loss of independence, and eventually the inability to perform daily activities without assistance. That progression makes the question of what actually repairs nerve tissue (not just what quiets the pain signal) clinically urgent.
Why Medication Alone Is Not Enough
The pharmaceutical approach to neuropathy is, by design, symptom management. Gabapentin, pregabalin, duloxetine, opioids: these drugs modulate the pain signal. They do not repair the nerve. For many patients, they create their own problems: dependency, cognitive fog, gastrointestinal disruption, and a gradual escalation in dosage as the body builds tolerance while the underlying damage continues to progress.
None of this means medication is useless. For acute pain management, it serves a purpose. But a treatment plan that begins and ends with symptom suppression leaves the root cause entirely unaddressed. The nerve stays damaged. The function stays compromised. The progression continues.
The clinical question that matters is whether anything can stimulate actual nerve repair, and that is where the photobiomodulation research becomes relevant.
How Red Light Therapy Works on Damaged Nerves
Red light therapy uses wavelengths in the red and near-infrared spectrum (typically 630 to 1200 nm) to penetrate tissue and interact with cellular structures. The mechanisms are well-documented across peer-reviewed literature. In nerve tissue specifically, five distinct biological processes drive the therapeutic effect.
Restoring Cellular Energy Production
Damaged nerve cells are energy-starved. They require enormous amounts of ATP (the cell's primary energy molecule) to function and repair, and damage compromises their ability to produce it.
Red light photons are absorbed by cytochrome c oxidase, a key enzyme in the mitochondrial respiratory chain. This absorption accelerates electron transfer and boosts ATP production, effectively restoring the energy supply damaged cells need to initiate and sustain repair processes. A 2015 study confirmed that low-level light therapy increases mitochondrial membrane potential and ATP synthesis, with peak cellular response occurring between three and six hours after exposure. This energy restoration is foundational; every other healing mechanism depends on the cell having sufficient fuel to execute it.
Triggering Nerve Growth Factors
Red light therapy stimulates the release of critical growth proteins: brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), glial-derived neurotrophic factor (GDNF), and vascular endothelial growth factor (VEGF). These proteins are essential for nerve cell survival, growth, and regeneration.
A 2019 study demonstrated that photobiomodulation at 660 nm reduced oxidative stress and induced BDNF expression in neural tissue. These growth factors also promote the formation of myelin, the protective insulating sheath around nerve fibers that enables proper signal transmission. When myelin degrades (a hallmark of many neuropathy cases), signal transmission breaks down. Restoring it is not optional for functional recovery.
Reducing Inflammation Around Damaged Nerves
Chronic inflammation perpetuates nerve damage. Inflamed tissue compresses nerves, generates pain signals, and creates a biochemical environment hostile to repair. Red light therapy inhibits inflammatory signaling pathways and reduces pro-inflammatory cytokines, breaking the inflammation cycle that keeps damaged nerves from healing.
Clinical research has demonstrated significant reductions in inflammatory cell infiltration after photobiomodulation application. The anti-inflammatory effect is not temporary symptom relief (like icing a joint); it addresses the biochemical signaling that sustains chronic inflammation at the cellular level, creating conditions where repair can actually proceed.
Rebuilding the Myelin Sheath
In many neuropathy cases, the myelin sheath protecting nerve fibers becomes damaged or degraded. Myelin is produced and maintained by Schwann cells, specialized cells essential to peripheral nervous system health.
Research shows that low-level laser therapy stimulates Schwann cell proliferation and NGF gene expression, promoting both the repair of existing myelin and the generation of new protective covering. The same light exposure also reduces the inflammatory cytokines that attract immune cells responsible for myelin damage in the first place. The combination, more Schwann cell activity plus less immune-mediated destruction, addresses myelin loss from both directions.
Improving Blood Supply to Nerve Tissue
Damaged nerves need oxygen and nutrients to heal. Red light therapy increases nitric oxide production, which dilates blood vessels and improves circulation to compromised tissue. It also stimulates angiogenesis, the formation of new capillaries, ensuring that damaged nerve tissue receives adequate resources for repair while clearing metabolic waste.
This vascular mechanism is particularly critical for diabetic neuropathy patients. Compromised blood flow is both a cause and a consequence of diabetic nerve damage; improving circulation addresses the supply chain problem that stalls healing even when the cellular machinery is otherwise functional.
What the Clinical Research Shows
The evidence base for photobiomodulation in neuropathy has expanded substantially in the past five years. The findings are consistent across multiple research teams, patient populations, and neuropathy types.
Diabetic Neuropathy
A 2023 study found that visible and infrared low-level light therapy significantly improved symptoms of diabetic neuropathy without side effects. A systematic review in Current Diabetes Reviews concluded that photobiomodulation is an effective, non-invasive means of improving neuropathic pain and altered plantar pressure distribution in diabetic peripheral neuropathy. A 2024 clinical trial confirmed that photobiomodulation effectively reduces peripheral neuropathic pain and improves plantar pressure distribution, reducing the risk of further complications. And a 2025 study measuring neuron-specific biomarkers found reduced neuropathic symptoms, improved protective foot sensation, better quality of life, and reduced pain in the intervention group.
Chemotherapy-Induced Peripheral Neuropathy
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most debilitating side effects of cancer treatment, and one of the hardest to address pharmacologically. A 2020 overview from leading research teams concluded that photobiomodulation might be an effective strategy to manage CIPN, with very encouraging clinical reports. A 2022 randomized, placebo-controlled pilot trial found promising results for CIPN prevention with photobiomodulation in breast cancer patients, alongside improved quality of life in the treatment group.
Neuropathic Pain Broadly
A 2025 comprehensive review in Frontiers in Photonics assessed the full body of evidence and concluded that photobiomodulation therapy stands as a biologically grounded and safe approach capable of addressing the multifactorial nature of neuropathic pain, positioning local photobiomodulation as the most promising and clinically actionable modality for neuropathic pain management. A 2024 systematic review in BMC Neurology examining combination therapies confirmed the therapeutic role of photobiomodulation across a wide range of central and peripheral neurological disorders.
The pattern across these studies is consistent: reduced pain intensity, improved sensory function, accelerated nerve healing, and no significant adverse effects. The research spans diabetic neuropathy, chemotherapy-induced neuropathy, trigeminal neuralgia, and other peripheral nerve conditions.
What makes photobiomodulation compelling for neuropathy is that it operates on the biology of the nerve itself. You're not blocking a pain signal. You're restoring the cellular energy production, growth factor signaling, and blood supply that damaged nerves need to actually repair. The clinical data across multiple neuropathy types now supports that mechanism.— William Carter, MD
What an Effective Treatment Protocol Looks Like
Nerves are among the slowest-healing tissues in the body. That biological reality shapes everything about how red light therapy needs to be applied for neuropathy. Isolated sessions produce isolated results. Consistent daily treatment, combined with the supporting conditions nerve tissue needs to heal, produces measurable improvement.
Consistent Daily Light Therapy
Daily treatment of approximately 20 minutes is the protocol supported by the research. Photobiomodulation works by stimulating cellular energy production, growth factor release, and tissue repair processes that require sustained activation over weeks and months. Skipping sessions interrupts the repair cascade, delaying results.
The Neuropathy Light Therapy System™ was designed around this daily-use requirement. It uses 200 triple-chip medical LED diodes (600 light chips total) delivering red and near-infrared wavelengths at up to 200 mW/cm² irradiance across an extra-large treatment area shaped to wrap the foot and ankle where neuropathy concentrates. The Pulsing mode cycles the light delivery so that cells absorb more photon energy per session, increasing the therapeutic dose within the same treatment window.
The wavelengths, irradiance levels, and session protocols the CuraYou system uses are consistent with what a growing number of US clinics now employ in structured neuropathy treatment programs. Triangle Regenerative Medicine in Chapel Hill, NC (Thomas Buchheit, MD) uses photobiomodulation for peripheral neuropathy. Active Spine & Joint Institute across multiple New Jersey locations combines low-level light therapy with electrostimulation and nutrition in their Active Neuropathy Method. Balance Wellspace in Roanoke, VA runs a peripheral neuropathy program combining LLLT, physical rehab, and dietary optimization. These are independent clinics; CuraYou has no affiliation with them. Their adoption of photobiomodulation in clinical neuropathy practice is the relevant signal: the science has moved from research papers into treatment rooms, and the CuraYou system delivers comparable light parameters in a home-use format with a structured daily protocol.
Supporting the Nerve Healing Environment
Light therapy provides the cellular stimulus. But nerves healing from significant damage also need raw materials and functional challenge to recover fully.
Nerve-support supplementation provides the micronutrients that damaged nerves require for repair. The evidence is strongest for alpha-lipoic acid: the SYDNEY 2 trial (Ziegler et al., 2006, Diabetes Care, n=181) found that 600 mg daily oral alpha-lipoic acid produced statistically significant symptom improvement versus placebo. Acetyl-L-carnitine has morphological evidence behind it: Sima et al., 2005 (Diabetes Care, n=1,257 across two pooled RCTs) demonstrated significant improvement in sural nerve fiber numbers and regenerating nerve fiber clusters at 500 mg and 1,000 mg three times daily, which is evidence of actual nerve regeneration, not just symptom relief. Benfotiamine (vitamin B1) showed improvement in per-protocol analysis in the BENDIP trial (Stracke et al., 2008, n=165) at 600 mg daily, though the intention-to-treat result narrowly missed statistical significance; the evidence is suggestive but weaker than for alpha-lipoic acid or acetyl-L-carnitine.
One safety note that any MD-reviewed article on this topic must include: vitamin B6 (pyridoxine) at elevated doses can itself cause peripheral neuropathy. The US Tolerable Upper Intake Level is 100 mg/day; the European Food Safety Authority revised their limit down to 12 mg/day in 2023 specifically due to peripheral neuropathy risk. B6 supplementation should correct a confirmed deficiency, not serve as therapeutic megadosing. If you are supplementing B-vitamins for neuropathy, discuss dosing with your physician.
Targeted exercise matters because nerves are communication pathways. Even when the nerve fiber itself heals, the functional pathways for balance, coordination, and sensation don't automatically restore. They need to be challenged and retrained through specific movement. Balance exercises, proprioception work, and guided walking protocols are part of the treatment program included with the Neuropathy Light Therapy System™.
Dietary inflammation reduction removes one of the obstacles to healing. Processed foods drive systemic inflammation that compounds nerve damage. Cleaning up the dietary environment doesn't heal nerves directly, but it stops making the problem worse while the light therapy and supplementation do their work.
The system includes a structured treatment plan covering all four components. Multi-component neuropathy treatment programs at US clinics typically run from several thousand dollars for a three-month protocol to significantly more for longer or more intensive programs. The CuraYou system brings a comparable protocol (daily photobiomodulation at clinical wavelengths and irradiance, plus structured exercise, dietary, and supplementation guidance) to a home-use format at a fraction of that cost.
